Madhav Seshadri1, Cheng-Kui Qu. 1. Department of Pediatrics, Division of Hematology and Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
PURPOSE OF REVIEW: Hematopoietic stem cells (HSCs) are a population of cells in the bone marrow which can self-renew, differentiate into late lineage progenitors, or remain quiescent. HSCs exist alongside several cell types in the bone marrow microenvironment that comprise the stem cell niche. These cells regulate HSC function and can contribute to leukemogenesis. In this review we will discuss recent advances in this field. RECENT FINDINGS: In the vascular niche, arteriolar and sinusoidal zones appear to play distinct roles in HSC function. Endothelial cells modulate HSC function via Notch and other signaling pathways. In the endosteal niche multiple cell types regulate HSCs. Osteoblasts promote HSC quiescence via secreted factors and possibly physical interactions, whereas adipocytes may oppose HSC quiescence. The balance of these opposing factors depends on metabolic cues. Feedback from HSC-derived cells, including macrophages and megakaryocytes also appears to regulate HSC quiescence. Dysfunction of the bone marrow microenvironment, including mesenchymal stem cell-derived stromal cells and the sympathetic nervous system can induce or alter the progression of hematologic malignancies. SUMMARY: Many cell types in the bone marrow microenvironment affect HSC function and contribute to malignancy. Further understanding how HSCs are regulated by the microenvironment has clinical implications for stem cell transplantation and other therapies for hematologic malignancies.
PURPOSE OF REVIEW: Hematopoietic stem cells (HSCs) are a population of cells in the bone marrow which can self-renew, differentiate into late lineage progenitors, or remain quiescent. HSCs exist alongside several cell types in the bone marrow microenvironment that comprise the stem cell niche. These cells regulate HSC function and can contribute to leukemogenesis. In this review we will discuss recent advances in this field. RECENT FINDINGS: In the vascular niche, arteriolar and sinusoidal zones appear to play distinct roles in HSC function. Endothelial cells modulate HSC function via Notch and other signaling pathways. In the endosteal niche multiple cell types regulate HSCs. Osteoblasts promote HSC quiescence via secreted factors and possibly physical interactions, whereas adipocytes may oppose HSC quiescence. The balance of these opposing factors depends on metabolic cues. Feedback from HSC-derived cells, including macrophages and megakaryocytes also appears to regulate HSC quiescence. Dysfunction of the bone marrow microenvironment, including mesenchymal stem cell-derived stromal cells and the sympathetic nervous system can induce or alter the progression of hematologic malignancies. SUMMARY: Many cell types in the bone marrow microenvironment affect HSC function and contribute to malignancy. Further understanding how HSCs are regulated by the microenvironment has clinical implications for stem cell transplantation and other therapies for hematologic malignancies.
Authors: Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette Journal: Cell Date: 2006-01-27 Impact factor: 41.582
Authors: Yucai Xie; Tong Yin; Winfried Wiegraebe; Xi C He; Diana Miller; Danny Stark; Katherine Perko; Richard Alexander; Joel Schwartz; Justin C Grindley; Jungeun Park; Jeff S Haug; Joshua P Wunderlich; Hua Li; Simon Zhang; Teri Johnson; Ricardo A Feldman; Linheng Li Journal: Nature Date: 2008-12-03 Impact factor: 49.962
Authors: Ingrid G Winkler; Valérie Barbier; Bianca Nowlan; Rebecca N Jacobsen; Catherine E Forristal; John T Patton; John L Magnani; Jean-Pierre Lévesque Journal: Nat Med Date: 2012-10-21 Impact factor: 53.440
Authors: José L Sardina; Guillermo López-Ruano; Rodrigo Prieto-Bermejo; Beatriz Sánchez-Sánchez; Alejandro Pérez-Fernández; Luis Ignacio Sánchez-Abarca; José Antonio Pérez-Simón; Luis Quintales; Jesús Sánchez-Yagüe; Marcial Llanillo; Francisco Antequera; Angel Hernández-Hernández Journal: Biochim Biophys Acta Date: 2014-09-03
Authors: Jenny N Poynter; Michaela Richardson; Cindy K Blair; Michelle A Roesler; Betsy A Hirsch; Phuong Nguyen; Adina Cioc; Erica Warlick; James R Cerhan; Julie A Ross Journal: Cancer Epidemiol Date: 2015-12-22 Impact factor: 2.984
Authors: Adam Greenbaum; Yen-Michael S Hsu; Ryan B Day; Laura G Schuettpelz; Matthew J Christopher; Joshua N Borgerding; Takashi Nagasawa; Daniel C Link Journal: Nature Date: 2013-02-24 Impact factor: 49.962
Authors: Daniela S Krause; Keertik Fulzele; André Catic; Chia Chi Sun; David Dombkowski; Michael P Hurley; Sanon Lezeau; Eyal Attar; Joy Y Wu; Herbert Y Lin; Paola Divieti-Pajevic; Robert P Hasserjian; Ernestina Schipani; Richard A Van Etten; David T Scadden Journal: Nat Med Date: 2013-10-27 Impact factor: 53.440
Authors: Sara Ortiz-Rivero; Cristina Baquero; Luis Hernández-Cano; Juan José Roldán-Etcheverry; Sara Gutiérrez-Herrero; Cristina Fernández-Infante; Víctor Martín-Granado; Eduardo Anguita; José María de Pereda; Almudena Porras; Carmen Guerrero Journal: Cell Commun Signal Date: 2018-12-19 Impact factor: 5.712
Authors: Fengjie Li; Rong Zhang; Changpeng Hu; Qian Ran; Yang Xiang; Lixin Xiang; Li Chen; Yang Yang; Shengwen Calvin Li; Gang Zhang; Zhongjun Li Journal: Front Cell Dev Biol Date: 2021-09-03